➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
Merck
Moodys
Medtronic
Express Scripts

Last Updated: October 21, 2021

DrugPatentWatch Database Preview

Litigation Details for ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. (D.N.J. 2019)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC.
The small molecule drug covered by the patent cited in this case is ⤷  Try it Free .

Details for ACTELION PHARMACEUTICALS LTD v. AUROBINDO PHARMA USA INC. (D.N.J. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-07-16 1 Complaint expiration of United States Patent No. 7,094,781 (“the ’781 patent” or “the patent-in-suit”). …infringement of Claim 11 of the ’781 patent. This action arises under the patent laws of the United States, 35…781 patent titled, “Sulfamides and Their Use as Endothelin Receptor Antagonists.” The ’781 patent duly…expiration of the ’781 patent, Aurobindo has infringed Claim 11 of the ’781 patent under 35 U.S.C. § 271…expiration of the ’781 patent, Aurobindo will infringe Claim 11 of the ’781 patent under 35 U.S.C. §§ 271 External link to document
2020-07-15 44 Judgment - Consent ii) the term “Licensed Patent” shall mean United States Patent Number 7,094,781; and (iii) the term “Affiliate…the Licensed Patent are valid and enforceable, and that the claims of the Licensed Patent would be infringed…Aurobindo Product prior to expiration of the Licensed Patent. 4. Unless otherwise specifically…Document 44 Filed 07/15/20 Page 3 of 4 PageID: 447 Patent, on its own part or through any Affiliate, by making…2019 15 July 2020 3:19-cv-15437 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Moodys
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.